Biodexa Pharmaceuticals (BDRX) Goodwill (2017 - 2022)

Biodexa Pharmaceuticals has disclosed Goodwill across 4 years of filings, most recently posting $1.3 million for Q2 2022.

• In Q2 2022, Goodwill changed N/A year-over-year to $1.3 million; the TTM figure through Jun 2022 stood at $1.3 million (changed N/A YoY), while the FY2019 annual figure was $2.9 million, down 4.4% from the prior year.
• Goodwill came in at $1.3 million for Q2 2022 at Biodexa Pharmaceuticals, down from $3.0 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $9.1 million in Q2 2018 to a low of $1.3 million in Q2 2022.
• Average Goodwill over 3 years is $4.1 million, with a median of $3.0 million recorded in 2019.
• Year-over-year, Goodwill plunged 83.36% in 2018 and fell 0.08% in 2019.
• Over 3 years, Goodwill stood at $3.0 million in 2018, then retreated by 0.08% to $3.0 million in 2019, then plunged by 57.71% to $1.3 million in 2022.
• Per Business Quant data, the three most recent Goodwill figures were $1.3 million in Q2 2022, $3.0 million in Q4 2019, and $3.0 million in Q4 2018.